William E. Albrecht - 15 Dec 2025 Form 4 Insider Report for Vital Energy, Inc. (VTLE)

Role
Director
Signature
/s/ Mark D. Denny as attorney-in-fact for William E. Albrecht
Issuer symbol
VTLE
Transactions as of
15 Dec 2025
Net transactions value
$0
Form type
4
Filing time
15 Dec 2025, 16:53:59 UTC
Previous filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Albrecht William E Director 521 E. 2ND STREET, SUITE 1000, TULSA /s/ Mark D. Denny as attorney-in-fact for William E. Albrecht 15 Dec 2025 0001433667

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTLE Common Stock Options Exercise +22,972 +210% 33,923 15 Dec 2025 Direct F1, F2
transaction VTLE Common Stock Disposed to Issuer -33,923 -100% 0 15 Dec 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTLE Deferred Stock Units Options Exercise -22,972 -100% 0 15 Dec 2025 Common Stock 22,972 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William E. Albrecht is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent.
F2 Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date).